CIBC World Market’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,215
| Closed | -$211K | – | 1312 |
|
|
2024
Q4 | $211K | Buy |
+3,215
| New | +$211K | ﹤0.01% | 1196 |
|
|
2019
Q2 | – | Sell |
-4,701
| Closed | -$241K | – | 1118 |
|
|
2019
Q1 | $241K | Buy |
+4,701
| New | +$241K | ﹤0.01% | 972 |
|
|
2018
Q4 | – | Sell |
-73,452
| Closed | -$4.11M | – | 1087 |
|
|
2018
Q3 | $4.11M | Buy |
+73,452
| New | +$4.11M | 0.02% | 321 |
|
|
2018
Q2 | – | Sell |
-4,650
| Closed | -$229K | – | 1148 |
|
|
2018
Q1 | $229K | Hold |
4,650
| – | – | ﹤0.01% | 1015 |
|
|
2017
Q4 | $239K | Hold |
4,650
| – | – | ﹤0.01% | 668 |
|
|
2017
Q3 | $242K | Hold |
4,650
| – | – | ﹤0.01% | 633 |
|
|
2017
Q2 | $240K | Hold |
4,650
| – | – | ﹤0.01% | 971 |
|
|
2017
Q1 | $234K | Sell |
4,650
-7,143
| -61% | -$359K | ﹤0.01% | 840 |
|
|
2016
Q4 | $556K | Buy |
11,793
+4,413
| +60% | +$208K | ﹤0.01% | 707 |
|
|
2016
Q3 | $368K | Buy |
7,380
+144
| +2% | +$7.18K | ﹤0.01% | 758 |
|
|
2016
Q2 | $348K | Sell |
7,236
-1,257
| -15% | -$60.5K | ﹤0.01% | 728 |
|
|
2016
Q1 | $388K | Sell |
8,493
-4,908
| -37% | -$224K | ﹤0.01% | 656 |
|
|
2015
Q4 | $722K | Sell |
13,401
-14,607
| -52% | -$787K | ﹤0.01% | 547 |
|
|
2015
Q3 | $1.38M | Sell |
28,008
-18,978
| -40% | -$936K | 0.01% | 374 |
|
|
2015
Q2 | $2.74M | Buy |
46,986
+16,620
| +55% | +$968K | 0.01% | 274 |
|
|
2015
Q1 | $1.75M | Buy |
30,366
+10,482
| +53% | +$602K | 0.01% | 322 |
|
|
2014
Q4 | $1M | Sell |
19,884
-11,757
| -37% | -$593K | ﹤0.01% | 445 |
|
|
2014
Q3 | $1.48M | Buy |
31,641
+24,108
| +320% | +$1.13M | 0.01% | 335 |
|
|
2014
Q2 | $339K | Buy |
7,533
+2,022
| +37% | +$91K | ﹤0.01% | 594 |
|
|
2014
Q1 | $233K | Buy |
+5,511
| New | +$233K | ﹤0.01% | 653 |
|